Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Session 8 - Luminal breast cancer

ET and biological agents advanced breast cancer

Date

01 Oct 2022

Session

Session 8 - Luminal breast cancer

Topics

Endocrine Therapy

Tumour Site

Breast Cancer

Presenters

C. Criscitiello, IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

01 Oct 2022

Primary systemic therapy (neoadjuvant and adjuvant)

Presenter: Barbara Pistilli, FR

Session: Session 8 - Luminal breast cancer

Resources:

Slides

Webcast

01 Oct 2022

Adjuvant endocrine therapy and CDK 4-6 inhibitors

Presenter: C. Sotiriou, BE

Session: Session 8 - Luminal breast cancer

Resources:

Slides

Webcast

01 Oct 2022

How to treat HER2 low breast cancer

Presenter: J. Cortés, ES

Session: Session 8 - Luminal breast cancer

Resources:

Slides

Webcast

01 Oct 2022

Participant Clinical Case: Massive liver metastases in Luminal B breast cancer

Presenter: C. Gawiński, PL

Session: Session 8 - Luminal breast cancer

Resources:

Slides

Webcast

01 Oct 2022

Participant Clinical Case: Management of metastatic breast cancer

Presenter: E. Ruci, AL

Session: Session 8 - Luminal breast cancer

Resources:

Slides

Webcast

01 Oct 2022

Participant Clinical Case: A case of disabling arthritis induced by iCDKs and long term response to Exemestane/Everolimus in 3rd line

Presenter: J. Albuquerque, PT

Session: Session 8 - Luminal breast cancer

Resources:

Slides

Webcast